AGCM has awarded synbrAIn its Legality Rating
This recognition confirms the company's commitment to ethics, transparency, and integrity in artificial intelligence research and development.... Read more.
Together to Understand Who We Are: synbrAIn’s Team Building Event
"Together to Understand Who We Are" was the theme of synbrAIn's 2026 Team Building event. An experience that brought together strategy, people, and nature to strengthen... Read more.
LLM and Software Development: The synbrAIn Seminar at the University of Enna Kore
Find out how synbrAIn addressed the topic of LLMs in software development during the seminar at the University of Enna Kore. Opportunities, risks, and future prospects... Read more.
synbrAIn wins the Lombardy Region’s FESR “Strategic Technologies” tender with the O-MAI project
O-MAI is the synbrAIn project that is part of the strategic initiative for the evolution of precision medicine in Lombardy.... Read more.
COPAILOT: synbrAIn awarded funding under Regione Lombardia’s Collabora & Innova call
synbrAIn, an italian company specializing in the development of ethical and human-centered Artificial Intelligence solutions for Digital Healthcare, has been awarded... Read more.
synbrAIn’s code of ethics: responsibility, transparency, and continuous business improvement
Milan, – synbrAIn announces the publication of its Code of Ethics, an essential tool that defines the values, responsibilities, and behaviors expected of all... Read more.
synbrAIn has obtained UNI/PDR 125:2022 certification for gender equality
Milan, July 15, 2025 – synbrAIn is proud to announce that it has obtained UNI/PDR 125:2022 certification, one of the most authoritative national standards on gender... Read more.
synbrAIn Achieves ISO 9001 Certification
We are pleased to announce that synbrAIn has extended its ISO 9001 Certification for the “Quality Management System” to its offices in Palermo and Verona.... Read more.
synbrAIn Achieves ISO 13485 Certification
synbrAIn has obtained ISO 13485 Certification, the standard for Quality Management of Medical Devices, placing patient safety at the center. This certification aims... Read more.
Team Building 2024: synbrAIn and Sentic Lab
During the first day of Team Building 2024, the new Milan headquarters was officially inaugurated, and an analysis was conducted on the results achieved in 2023... Read more.
synbrAIn and Emme Esse MS: A Success at the SIRM 2024 Congress
The joint Congress of SIRM (Italian Society of Medical and Interventional Radiology) with AIMN (Italian Association of Nuclear Medicine and Molecular Imaging) and... Read more.
University of Enna Kore and synbrAIn: A Successful Collaboration for Technological Innovation
Palermo, 19/07/2024 – The master’s degrees in Artificial Intelligence Engineering and Cybersecurity awarded by the University of Enna Kore (UNIKORE) are the... Read more.
Roberto Pagani on the Evolution of synbrAIn
Milan, 02/02/2024 – In an exclusive interview with Tracce, Roberto Pagani, founder and CEO of synbrAIn, reflects on the most significant moments that have shaped... Read more.
MEDIMAG-IA: Senticlab Team Wins the Hackathon!
We are delighted to announce a new success in the field of medical imaging: Senticlab’s team has won the hackathon organized by the Regional Center of Excellence... Read more.
New Milestone in Kidney Tumor Segmentation: KiTS 2023
The continuous advancement in medicine and artificial intelligence is enriched by a series of open competitions designed to challenge data scientists, medical professionals,... Read more.
synbrAIn and SenticLab: Three Days of Team Building to Celebrate Company Growth
n recent years, synbrAIn has achieved major recognition and funding at both national and international levels, thanks to its strong work culture and commitment to... Read more.
Story Time: Roberto Pagani Talks About synbrAIn and AI Innovation
In an exclusive video interview with Story Time, Roberto Pagani, CEO of synbrAIn, offered insight into the world of this promising technology company. With a strong... Read more.
A Fuzzy-Based Clinical Decision Support System for Coeliac Disease
Coeliac disease (CD) is a permanent inflammatory disease of the small intestine characterized by the destruction of the mucous membrane of this intestinal tract.... Read more.
Emme Esse Becomes a New synbrAIn Shareholder
In recent years, synbrAIn has made significant strides in the field of Digital Healthcare, developing numerous AI and machine learning-driven solutions to support... Read more.
synbrAIn Acquires SenticLab
After four years of continuous collaboration, synbrAIn has acquired one of its key business partners: SenticLab. Founded in April 2017 in Iași, Northeastern Romania,... Read more.
Major Achievement for SenticLab in the MIA-COV19D Competition at ICCV 2021
MIA-COV19D is an international competition organized by the University of Lincoln (UK), aimed at developing new solutions for identifying COVID-19-related diseases... Read more.
synbrAIn Announces New Strategic Partnership with EMME ESSE
As we announced a few weeks ago, the launch of MS humanAId by Emme Esse has seen synbrAIn’s active involvement in developing a system that leverages artificial... Read more.
MS HUMANAID Now Operational in More Hospitals Across Brianza
The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling... Read more.
SenticLab, synbrAIn’s Research Partner, Develops a Solution to Identify Tuberculosis Types from Radiographic Images
ImageCLEF is an international initiative organized by the CLEF initiative lab, aimed at fostering the development of new AI and machine learning-based solutions... Read more.
MS HUMANAID: Artificial Intelligence Supporting COVID-19 Diagnosis
Among the various collaborations initiated by synbrAIn, one stands out as particularly significant in the healthcare sector: its partnership with Emme Esse. Emme... Read more.
synbrAIn Continues Its Growth!
synbrAIn was born in 2019 from the merger of GetLeads and Arcaspark. Since then, the company has been experiencing constant growth in terms of personnel, know-how,... Read more.
SenticLab Achieves a Milestone at NODE21 for Lung Cancer Detection
Lung cancer is a severe disease that leads to a high number of fatalities. Among all types of cancer, it is the leading cause of cancer-related deaths worldwide.... Read more.
COVID-X to Fund a New synbrAIn Project
As part of its ongoing commitment to innovation, the synbrAIn team has launched AIDE-X, an acronym for Artificial Intelligence for Early Detection of Lung Diseases... Read more.
synbrAIn secures new European funding through the DIGI-B-CUBE program
In the fields of medicine and healthcare, it is not uncommon for private and public companies to invest significantly in research and new technologies. Not surprisingly,... Read more.
